InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,264.40
(
0.00%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.82
(
0.47%
)
Bitcoin
61,279.61
(
-0.54%
)
Post# of 345997
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

freethemice

Send PM Follow Ignore
Followers 51
Posts 1681
Boards Moderated 0
Alias Born 02/15/2007

freethemice

Re: None

Saturday, 07/14/2012 1:02:35 AM

Saturday, July 14, 2012 1:02:35 AM

Post# of 345997
Moving on to pancreatic cancer. Here is the table of treatment/control MOS. Note that 5 of the 12 trials
have treatment MOS < control MOS. I think bavi + gemcitabine can beat the best here, the FOLFIRINOX trial.
Hopefully we will see the control MOS by the end of the year.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CDMO News
More CDMO News
InvestorsHub NewsWire

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!